lysine has been researched along with Anti-Phospholipid Antibody Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapman, MG; Guerin, J; Iverson, GM; Krilis, SA; Reddel, S; Sheng, Y | 1 |
1 other study(ies) available for lysine and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome.
Topics: Anticoagulants; Antiphospholipid Syndrome; beta 2-Glycoprotein I; Binding Sites; Binding, Competitive; Cardiolipins; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Fibrinolysin; Glycoproteins; Haptoglobins; Heparin; Humans; Lysine; Models, Biological; Mutagenesis, Site-Directed; Mutation; Peptides; Phospholipids; Protein Binding; Protein Structure, Tertiary; Time Factors | 2002 |